Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Pegfilgrastim
Related studies linked through entity extraction aliases.
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
- Status
- UNKNOWN
- Phase
- PHASE3
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
- Status
- COMPLETED
- Phase
- PHASE3
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE3
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
- Status
- TERMINATED
- Phase
- PHASE1
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE4
Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta
- Status
- COMPLETED
- Phase
- PHASE1
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
- Status
- COMPLETED
- Phase
- PHASE3